Status:
SUSPENDED
Stress Phenotypes and Preterm Birth
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Preterm Birth
Inflammation
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Pregnancy ends in preterm birth (PTB) for approximately 1 in 10 women, though more often for Non-Hispanic Black women, 14.12% PTB rate, compared to 9.09% for Non-Hispanic White women. Psychosocial str...
Detailed Description
At odds with common assumptions - and hope, pregnancy ends in preterm birth (PTB) for approximately 1 in 10 women. Yearly PTB affects 15 million infants worldwide and 386,580 in the United States. PTB...
Eligibility Criteria
Inclusion
- Healthy, singleton pregnancy, between the ages of 18-45
Exclusion
- Currently smoking cigarettes, drinking alcohol, taking dugs, taking medications regularly (other than prenatal vitamins), multiple fetal pregnancy, inflammatory conditions including rheumatoid arthritis, lupus, and multiple sclerosis, and not planning to deliver at CUMC
Key Trial Info
Start Date :
December 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05229666
Start Date
December 9 2021
End Date
November 1 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032